Labs and Industry Stakeholders Respond to FDA LDT Rule
Explore the response to the FDA's Laboratory Developed Tests, LDTs, final rule, including industry concessions, legal challenges, and legislative reactions.
Source: natlawreview.com
Stay updated with breaking news from Third Party Review Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore the response to the FDA's Laboratory Developed Tests, LDTs, final rule, including industry concessions, legal challenges, and legislative reactions.
This draft guidance provides FDA’s current thinking on the 510(k) Third Party Review Program and review of EUA requests by third party review organizations.
With comments due on the proposed LDT rule last week, FDA wasted no time updating the Unified Agenda to indicate that a final rule...
Previously, Robert Califf previewed his priorities, if confirmed, to the Senate HELP Committee.